Key result
This document is a citation guide for bibliographic references and does not contain clinical trial data.
Why the study?
Does an ELISA using synthetic peptides accurately detect antibodies in patients with chronic Chagas' disease compared to immunoradiometric assay?
Does an ELISA using synthetic peptides accurately detect antibodies in patients with chronic Chagas' disease compared to immunoradiometric assay?
An ELISA using synthetic peptides from T. cruzi antigens demonstrates high sensitivity for detecting chronic Chagas' disease, comparable to immunoradiometric assays.
No takes yet. Share an insight, caveat, or question.
ELISA with synthetic peptides may offer sensitive chronic Chagas detection; leaves open prospective validation before replacing immunoradiometric assays.
Vergara et al. (1992) studied this question. This document is a citation guide for bibliographic references and does not contain clinical trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: